Management of the Clinically Inapparent Adrenal Mass (Incidentaloma)

By M. Grumbach, B. Biller, G. Braunstein, K. Campbell, J. Carney, P. Godley, E. Harris, Joseph Lee, Y. Oertel, M. Posner and 2 more. Annals of Internal Medicine, 2003

938 citations recorded by the source corpus.

Subfields: Cancer Research, Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/863d5ade6be70ecb9dd5b73553dfd14246bd315f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Surgery

1. Joseph Lau

Citations in the corpus

• The clinically inapparent adrenal mass: update in diagnosis and management. (2004, methodology): “To provide a standard, the NIH Stateof-Science Conference panel recommended the 1-mg dexamethasone suppression test in all patients with incidentally detected adrenal masses (19).”
• American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations. (2009, neutral): “Suppression of the plasma cortisol level to 1.8 m g/dL has the best negative predictive value for Cushing syndrome (5 [EL 4]) .”
• Overdiagnosis in cancer. (2010, background): “small pulmonary nodules (40) and adrenal lesions (41,42) incidentally detected on CT.”